Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients

Related articles

28 Jun 2019 : Original article

Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates

Meghan Aversa, Luke Benvenuto, [...] Hanyoung Kim, Lori Shah, Hilary Robbins, B. Payne Stanifer, Frank D’Ovidio, Elena-Rodica R. Vasilescu, Joshua Sonett, Selim M. Arcasoy - Show fewer authors

DOI: 10.12659/AOT.915769

27 Aug 2019 : Original article

A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study

Jérôme Dumortier, Christophe Duvoux, [...] Laurence Dubel, Fabienne Bazin, Pauline Houssel-Debry - Show fewer authors

DOI: 10.12659/AOT.916041

23 Aug 2018 : Original article

Early Sirolimus-Based Immunosuppression is Safe for Lung Transplantation Patients: Retrospective, Single Arm, Exploratory Study

Jacek Wojarski, Sławomir Żegleń, [...] Marek Ochman, Wojtek Karolak - Show fewer authors

DOI: 10.12659/AOT.908471

07 Mar 2017 : Original article

Profiling Proteinic Changes Induced by Vildagliptin Treatment in a Mouse Lung Transplantation Model: The Role of Kininogen-1

Zheng Tang, Wei Zhai, [...] Zhiwei Wang, Zhipeng Hu, Min Zhang - Show fewer authors

DOI: 10.12659/AOT.902002

15 Aug 2014 : Original article

Volatility of Serum Creatinine Relative to Tacrolimus Levels Predicts Kidney Transplant Rejection

Sarah Schmid, Rhonda Bryce, [...] Bruce Reeder, Masud Rana, Punam Pahwa, Ahmed Shoker, Michael A.J. Moser - Show fewer authors

DOI: 10.12659/AOT.890815

30 Sep 2011

Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation

Kyota Fukazawa, Seigo Nishida, [...] Luz M. Aguina, Ernesto A. Pretto Jr. - Show fewer authors

30 Jun 2011

Malignancy after renal transplantation in the new era of immunosuppression

Ewa Watorek, Maria Boratynska, [...] Danuta Smolska, Dariusz Patrzalek, Marian Klinger - Show fewer authors

23 Mar 2011

Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of Tacrolimus in Chinese renal transplant patients

Ping Wu, Xuefeng Ni, [...] Mingli Wang, Xianlin Xu, Guanghua Luo, Yan Jiang - Show fewer authors

10 Aug 2018 : Original article

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study

Florentine Garaix, Marc Stern, [...] François-Xavier Lamy, Laurence Dubel, Nassim Kamar - Show fewer authors

DOI: 10.12659/AOT.908522

17 Mar 2017 : Original article

Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation

Diego Aguiar, Diego Martínez-Urbistondo, [...] Delia D'Avola, Mercedes Iñarrairaegui, Fernando Pardo, Fernando Rotellar, Bruno Sangro, Jorge Quiroga, Jose Ignacio Herrero - Show fewer authors

DOI: 10.12659/AOT.901556

11 Aug 2017 : Original article

Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation

Yutaka Hirano, Seiichiro Sugimoto, [...] Toshifumi Mano, Takeshi Kurosaki, Kentaroh Miyoshi, Shinji Otani, Masaomi Yamane, Motomu Kobayashi, Shinichiro Miyoshi, Takahiro Oto - Show fewer authors

DOI: 10.12659/AOT.904225

14 Mar 2013

Rapidly fatal disseminated acanthamoebiasis in a single lung transplant recipient

Kamyar Afshar, Ayana BoydKing, [...] Sivagini Ganesh, Cynthia Herrington, P. Michael McFadden - Show fewer authors

DOI: 10.12659/AOT.883846

12 May 2014 : Original article

Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats

Ivan Matia, Peter Fellmer, [...] Katrin Splith, Martin Varga, Milos Adamec, Ines Kämmerer, Linda Feldbrügge, Felix Krenzien, Hans-Michael Hau, Georgi Atanasov, Moritz Schmelzle, Sven Jonas - Show fewer authors

DOI: 10.12659/AOT.889870

29 Oct 2013

Lung cancer screening with low-radiation dose computed tomography after liver transplantation

Jose Ignacio Herrero, Gorka Bastarrika, [...] Delia D'Avola, Usua Montes, Jesus Pueyo, Mercedes Iñarrairaegui, Fernando Pardo, Jorge Quiroga, Javier Zulueta - Show fewer authors

DOI: 10.12659/AOT.884021

04 Mar 2013

Incidence of malignancies in cardiac allograft recipients – a single-center experience

Małgorzata Sobieszczańska-Małek, Krzysztof Komuda, [...] Małgorzata Piotrowska, Jerzy Korewicki, Grzegorz Małek, Przemysław Leszek, Tomasz Zieliński - Show fewer authors

DOI: 10.12659/AOT.883843

29 Jun 2012

Tacrolimus-induced nephrotoxicity and genetic variability: A review

Violette M.G.J. Gijsen, Parvaz Madadi, [...] Marie-Pierre Dube, Dennis A. Hesselink, Gideon Koren, Saskia N. de Wildt - Show fewer authors

DOI: 10.12659/AOT.883229

31 Mar 2012

Malignancy after kidney transplantation

Behzad Einollahi,

DOI: 10.12659/AOT.882649

05 Jan 2016 : Original article

Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization

Kyle M. Gardiner, Susan E. Tett, [...] Christine E. Staatz - Show fewer authors

DOI: 10.12659/AOT.895664

06 Dec 2016 : Original article

De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors

Albino Eccher, Luigino Boschiero, [...] Brett Delahunt, Luca Cima, Francesca Fior, Francesco Nacchia, Momo Rostand, Amedeo Carraro, Umberto Tedeschi, Gianluigi Zaza, Marilena Casartelli Liviero, Laura Zampicinini, Marco Chilosi, Giuseppe Feltrin, Claudio Rago, Antonietta D'Errico, Claudio Ghimenton, Guido Martignoni, Matteo Brunelli - Show fewer authors

DOI: 10.12659/AOT.900386

23 Jun 2014 : Original article

Incidence of malignant neoplasia after heart transplantation – a comparison between cyclosporine a and tacrolimus

Uwe Fuchs, Sarah Klein, [...] Armin Zittermann, Stephan M. Ensminger, Uwe Schulz, Jan F. Gummert - Show fewer authors

DOI: 10.12659/AOT.890199

14 Nov 2014 : Original article

Myeloproliferative Neoplasms and Recurrent Thrombotic Events in Patients Undergoing Liver Transplantation for Budd-Chiari Syndrome: A Single-Center Experience

Urszula Oldakowska-Jedynak, Mateusz Ziarkiewicz, [...] Bogna Ziarkiewicz-Wróblewska, Jadwiga Dwilewicz-Trojaczek, Barbara Górnicka, Paweł Nyckowski, Rafał Paluszkiewicz, Tadeusz Wróblewski, Krzysztof Zieniewicz, Waldemar Patkowski, Leszek Pączek, Wiesław Wiktor Jedrzejczak, Marek Krawczyk - Show fewer authors

DOI: 10.12659/AOT.890834

07 Aug 2013

Evolution to twice daily bolus intravenous tacrolimus: Optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant

Gregory I. Snell, Steven Ivulich, [...] Lauren Mitchell, Glen P. Westall, Bronwyn J. Levvey - Show fewer authors

DOI: 10.12659/AOT.883993

31 Dec 2003

Donor Transmitted Malignancies

Joseph Buell, Thomas M. Beebe, [...] Jennifer Trofe, Thomas G. Gross, Rita R. Alloway, Michael J. Hanaway, E. Steve Woodle - Show fewer authors

01 Aug 2004

Bone marrow transplantation in the course of hematological malignancies – Follow-up study in blood serum by ³¹P MRS

Małgorzata Kuliszkiewicz-Janus, Stanisław Baczyński, [...] Anna Jurczyk - Show fewer authors

21 Oct 2002

Allogenic stem cell transplantation following non-myeloablative conditioning regimens as adoptive immunotherapy in patients with hematological malignancies.

Alessandro Busca, Benedetto Bruno, [...] Mario Boccadoro, Franco Locatelli, Michele Falda - Show fewer authors